GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
116 hedge funds and large institutions have $39.6M invested in Sanofi Contingent Value Rights in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
Holders
116
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.09M | |
| 2 | +$427K | |
| 3 | +$365K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$260K |
| 5 |
SCM
Stonehill Capital Management
New York
|
+$127K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$63.3K | |
| 3 | -$25.3K | |
| 4 |
TL
TowerView LLC
New York
|
-$12.7K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$10.2K |